Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 1/2016

11.03.2016 | Original Article

Colposcopic Study of Lower Genital Tract Infections in HIV-Positive Women on Antiretroviral Therapy

verfasst von: Poorva Badkur, Kavita N. Singh, Vineeta Ghanghoriya

Erschienen in: The Journal of Obstetrics and Gynecology of India | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims and Objectives

To study the colposcopic findings and prevalence of lower genital tract infections in HIV-positive women on anti-retroviral therapy. To find correlation between colposcopic finding, m RNA HPV and cytology of lower genital tract infections in HIV-positive women on anti-retroviral therapy.

Materials and Methods

The present prospective observational study was conducted in the Department of Obstetrics and Gynaecology, Netaji Subhash Chandra Bose Medical College, Jabalpur, from 1 June 2013 to 31 October 2014. The data of the present study was recorded into computer and after proper validation, error checking, coding and decoding, the data was compiled and analysed using the SPSS Windows. Appropriate univariate and bivariate analysis were carried out using the Student’s t test and two-tailed Fisher exact test or Chi-square test for categorical variables.

Results and Conclusion

The present study concludes that the prevalence of lower genital tract infections is 25.3 % in HIV-positive women on anti-retroviral therapy. It revealed that 35 HIV-positive women on anti-retroviral therapy who were screened for m HPV RNA test, one came out to be positive (i.e. 2.8 %); thus, it can be said that there is an increased clearance of oncogenic HPV types in HIV-positive women on anti-retroviral therapy.
Literatur
1.
Zurück zum Zitat World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: WHO; 2001. World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: WHO; 2001.
2.
Zurück zum Zitat Wasserheit JN. The significance and scope of reproductive tract infections among third world women. Int J Gynaecol Obstet. 1989;30(S1):145–68.CrossRef Wasserheit JN. The significance and scope of reproductive tract infections among third world women. Int J Gynaecol Obstet. 1989;30(S1):145–68.CrossRef
3.
Zurück zum Zitat Tsui AO, Wasserheit JN, Haaga JG, editors Infection-free sex and protection in reproductive health in developing countries: expanding dimensions and building solutions. Washington, DC: National Academy Press; 1997. p. 40–84. Tsui AO, Wasserheit JN, Haaga JG, editors Infection-free sex and protection in reproductive health in developing countries: expanding dimensions and building solutions. Washington, DC: National Academy Press; 1997. p. 40–84.
4.
Zurück zum Zitat Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.CrossRefPubMedPubMedCentral Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Thomas JO. Cancer registration and diagnosis in Ibadan. Arch Ib Med. 2000;1(2):5–6. Thomas JO. Cancer registration and diagnosis in Ibadan. Arch Ib Med. 2000;1(2):5–6.
6.
Zurück zum Zitat Dey MP, Woodman CBJ. Epidemiology and pathogenesis of cervical cancer. In: Shingleton HM, Fowler WC, Jordan JA, Lawrence WD, editors. Gynaecologic oncology: current diagnosis and treatment. London: WB Saunders Company Ltd; 1996. p. 1–8. Dey MP, Woodman CBJ. Epidemiology and pathogenesis of cervical cancer. In: Shingleton HM, Fowler WC, Jordan JA, Lawrence WD, editors. Gynaecologic oncology: current diagnosis and treatment. London: WB Saunders Company Ltd; 1996. p. 1–8.
7.
Zurück zum Zitat Sorbye SW, Arbyn M, Fismen S, et al. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions. PLoS ONE. 2014;9(11):e112934.CrossRefPubMedPubMedCentral Sorbye SW, Arbyn M, Fismen S, et al. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions. PLoS ONE. 2014;9(11):e112934.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Waxman AG, Diaz ML. HPV, colposcopy and prevention of squamous anogenital tract malignancy. 2013;40(2):235–51. Waxman AG, Diaz ML. HPV, colposcopy and prevention of squamous anogenital tract malignancy. 2013;40(2):235–51.
9.
Zurück zum Zitat Singh Kavita N, Chakma T, Verma S. Colposcopic assessment of the cervix using the simplified Reid’s Colposcopic Index method. Curr Sci. 2009;96(3):386–91. Singh Kavita N, Chakma T, Verma S. Colposcopic assessment of the cervix using the simplified Reid’s Colposcopic Index method. Curr Sci. 2009;96(3):386–91.
10.
Zurück zum Zitat Cu-Uvin S, Hogan JH, Warren D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV) seropositive and high-risk HIV-seronegative women. Clin Infect Dis. 1999;29:1145–50.CrossRefPubMed Cu-Uvin S, Hogan JH, Warren D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV) seropositive and high-risk HIV-seronegative women. Clin Infect Dis. 1999;29:1145–50.CrossRefPubMed
11.
Zurück zum Zitat Blitz Sandra, Baxter Joanna, Raboud Janet, et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. JID. 2013;208(1):95–6. Blitz Sandra, Baxter Joanna, Raboud Janet, et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. JID. 2013;208(1):95–6.
12.
Zurück zum Zitat Ahdieh-Grant L, Li R, Levine AM, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2004;96:1070–6.CrossRefPubMed Ahdieh-Grant L, Li R, Levine AM, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2004;96:1070–6.CrossRefPubMed
13.
Zurück zum Zitat Hankins C, Coutlee F, Lapointe N, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women’s HIV Study Group. CMAJ. 1999;160:185–91.PubMedPubMedCentral Hankins C, Coutlee F, Lapointe N, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women’s HIV Study Group. CMAJ. 1999;160:185–91.PubMedPubMedCentral
14.
Zurück zum Zitat Firnhaber C, Van Le H, Pettifor A, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21:433–43.CrossRefPubMed Firnhaber C, Van Le H, Pettifor A, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21:433–43.CrossRefPubMed
15.
Zurück zum Zitat Heard I, Tassie JM, Schmitz V, et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol. 2000;96:403–9.PubMed Heard I, Tassie JM, Schmitz V, et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol. 2000;96:403–9.PubMed
16.
Zurück zum Zitat Levi JE, Fernandes S, Tateno AF, et al. Presence of multiple A human papillomavirus types in cervical samples from HIV- infected women. Gynecol Oncol. 2004;92:225–31.CrossRefPubMed Levi JE, Fernandes S, Tateno AF, et al. Presence of multiple A human papillomavirus types in cervical samples from HIV- infected women. Gynecol Oncol. 2004;92:225–31.CrossRefPubMed
17.
Zurück zum Zitat Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343–9.CrossRefPubMed Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343–9.CrossRefPubMed
18.
Zurück zum Zitat Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009;113:26–31.CrossRefPubMed Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009;113:26–31.CrossRefPubMed
Metadaten
Titel
Colposcopic Study of Lower Genital Tract Infections in HIV-Positive Women on Antiretroviral Therapy
verfasst von
Poorva Badkur
Kavita N. Singh
Vineeta Ghanghoriya
Publikationsdatum
11.03.2016
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0852-8

Weitere Artikel der Sonderheft 1/2016

The Journal of Obstetrics and Gynecology of India 1/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.